Neuralink Launches US and Canada Trials to Convert Thoughts into Text
Neuralink, founded by Elon Musk, is developing a brain implant that translates thoughts into text, initially aimed at helping speech-impaired individuals, with future plans for healthy users, raising ethical questions about human enhancement and technological integration. Clinical trials are set to evaluate safety and efficacy, while the technology sparks debates on the boundaries of human augmentation.